Literature DB >> 29709972

Comparative Analysis of Immune Responses to Outer Membrane Antigens OMP10, OMP19, and OMP28 of Brucella abortus.

Young Bin Im1, Woo Bin Park1, Myunghwan Jung1, Suk Kim2, Han Sang Yoo1,3.   

Abstract

Brucella infection is accompanied by cytokine production, which serves as an important factor to evaluate the innate and adaptive immune responses. Several researchers have been investigating the mechanisms involved in Brucella infection in the host. Here, we conducted an analytical study to define pathogenic pathways and immune mechanisms involved in Brucella infection by investigating the antigenic efficacy of recombinant outer membrane protein 10 (rOMP10), outer membrane protein 19 (rOMP19), and outer membrane protein 28 (rOMP28) in vitro and in vivo upon stimulation/immunization. Cytokine production was analyzed by nitric oxide (NO) assay and enzyme-linked immunosorbent assay (ELISA) after stimulation of RAW 264.7 cells and naive splenocytes with the recombinant proteins. Our results show that levels of NO, tumor necrosis factor (TNF)-α, and interleukin (IL)-6 increased in RAW 264.7 cells in a time-dependent manner following recombinant protein stimulation. In contrast, levels of interferon (IFN)-γ and IL-2 increased in naive splenocytes after stimulation with proteins. ELISA and ELISpot assays were performed after immunization of mice with recombinant proteins. rOMP28 greatly increased IFN-γ, IL-2, and TNF-α levels than IL-4 and IL-6 levels in vitro. Of the recombinant proteins, rOMP19 elicited a mixed Th1/Th2 immune response by increasing the number of IgG-secreting cells in vivo.

Entities:  

Keywords:  Brucella abortus; cytokine; immunogenicity; outer membrane protein

Mesh:

Substances:

Year:  2018        PMID: 29709972     DOI: 10.7883/yoken.JJID.2017.019

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  4 in total

1.  Evaluation of the Fluorescence Polarization Assay for the Diagnosis of Brucellosis in Goat Milk.

Authors:  Dianelys Sotolongo-Rodríguez; Ricardo Gomez-Flores; Magda Celina Navarro-Soto; Beatriz Arellano-Reynoso; Patricia Tamez-Guerra; Carlos Ramírez-Pfeiffer
Journal:  Vet Sci       Date:  2022-06-20

2.  Design of a multi-epitope vaccine candidate against Brucella melitensis.

Authors:  Min Li; Yuejie Zhu; Ce Niu; Xinru Xie; Gulishati Haimiti; Wenhong Guo; Mingkai Yu; Zhiqiang Chen; Jianbing Ding; Fengbo Zhang
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

3.  Proteomic and Antibody Profiles Reveal Antigenic Composition and Signatures of Bacterial Ghost Vaccine of Brucella abortus A19.

Authors:  Chuan-Yu He; Jiang-Hua Yang; Yin-Bo Ye; Hai-Long Zhao; Meng-Zhi Liu; Qi-Lin Yang; Bao-Shan Liu; Sun He; Ze-Liang Chen
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

4.  Immunization with a combination of recombinant Brucella abortus proteins induces T helper immune response and confers protection against wild-type challenge in BALB/c mice.

Authors:  Zhiqiang Li; Shuli Wang; Shujuan Wei; Guangli Yang; Chunmei Zhang; Li Xi; Jinliang Zhang; Yanyan Cui; Junfang Hao; Huan Zhang; Hui Zhang
Journal:  Microb Biotechnol       Date:  2022-02-15       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.